Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by gojotv!on Nov 24, 2021 4:58pm
429 Views
Post# 34163237

RE:RE:Valuation

RE:RE:Valuation

Two dollars??!
Wow, this Rumplestiltskin is turning gold into straw.
Must have read the story backwards.

I have no intention of selling under $50/share, FYI.
I'm the Charlton Heston of share ownership.
Try my cold, dead hands... just try 'em.

Rumpl3StiltSkin wrote: $2 US    ;-)
 

Camphikefish wrote: Hello everyone, been here reading most every post for at least 6 years and it feels like I know most of you even having never posted until now. Honestly, there are a lot of super sharp minds on this board and it can be intimidating to join in but here I am! For those of you who may have put a pencil to this, if we secure fda fast track and say we come in with a 60-70% CR from phase 2 with our NMIBC trial, what are we worth on the low side? I know there are other indications and then there's the Covid-19 opportunity ( which by the way, why have we not heard anything more about this ? ) but speaking strictly of NMIBC , what would we be valued at for a buyout ? And how realistic is a buyout and how soon ? I'm sure everyone's laughing at the newbie by now ! So many questions that everyone here wants the answers to ! Just throwing it out there . I could use the money one of these years . Thank you one and all and I promise no politics from this North Carolina medical device sales rep . 




<< Previous
Bullboard Posts
Next >>